Cargando…
Colorectal cysts as a validating tool for CAR therapy
BACKGROUND: Treatment of cancers has largely benefited from the development of immunotherapy. In particular, Chimeric Antigen Receptor (CAR) redirected T cells have demonstrated impressive efficacy against B-cell malignancies and continuous efforts are made to adapt this new therapy to solid tumors,...
Autores principales: | Dillard, Pierre, Lie, Maren, Baken, Elizabeth, Lobert, Viola Hélène, Benard, Emmanuelle, Köksal, Hakan, Inderberg, Else Marit, Wälchli, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268759/ https://www.ncbi.nlm.nih.gov/pubmed/32487146 http://dx.doi.org/10.1186/s12896-020-00623-0 |
Ejemplares similares
-
Combinatorial CAR design improves target restriction
por: Köksal, Hakan, et al.
Publicado: (2020) -
Chimeric antigen receptor preparation from hybridoma to T-cell expression
por: Köksal, Hakan, et al.
Publicado: (2019) -
Determination of CAR T cell metabolism in an optimized protocol
por: Joaquina, Sandy, et al.
Publicado: (2023) -
Sympathetic improvement of cancer vaccine efficacy
por: Inderberg, Else Marit, et al.
Publicado: (2020) -
Long-term surviving cancer patients as a source of therapeutic TCR
por: Inderberg, Else Marit, et al.
Publicado: (2020)